. "June" . "4"^^ . . "Tokarsk\u00FD, Jon\u00E1\u0161" . . "3376" . . "RIV/61989100:27640/14:86092158" . "Madejov\u00E1, Jana" . "Hlav\u00E1\u010D, Dominik" . "NL - Nizozemsko" . . . "http://www.sciencedirect.com/science/article/pii/S0169433214007715" . "Val\u00E1\u0161kov\u00E1, Marta" . . "Applied Surface Science" . . "27640" . . "Clay minerals are commonly used materials in pharmaceutical production both as inorganic carriers or active agents. The purpose of this study is the preparation and characterization of clay/antibacterial drug hybrids which can be further included in drug delivery systems for treatment oral infections. Novel nanocomposites with antibacterial properties were successfully prepared by ion exchange reaction from two types of kaolinite/urea intercalates and chlorhexidine diacetate. Intercalation compounds of kaolinite were prepared by reaction with solid urea in the absence of solvents (dry method) as well as with urea aqueous solution (wet method). The antibacterial activity of two prepared samples against Enterococcus faecalis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa was evaluated by finding the minimum inhibitory concentration (MIC). Antibacterial studies of both samples showed the lowest MIC values (0.01%, w/v) after 1 day against E. faecalis, E. coli and S. aureus. A slightly worse antibacterial activity was observed against P. aeruginosa (MIC 0.12%, w/v) after 1 day. Since samples showed very good antibacterial activity, especially after 1 day of action, this means that these samples can be used as long-acting antibacterial materials. Prepared samples were characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR). The experimental data are supported by results of molecular modelling."@en . "0169-4332" . "Antibacterial kaolinite/urea/chlorhexidine nanocomposites: Experiment and molecular modelling"@en . "305" . . "[D7E4B99895AB]" . "000336525400109" . . "Antibacterial kaolinite/urea/chlorhexidine nanocomposites: Experiment and molecular modelling" . "moleculal modelling; antibacterial activity; urea; kaolinite; chlorhexidine diacetate"@en . . "10.1016/j.apsusc.2014.04.008" . "Pazdziora, Erich" . . . . "Clay minerals are commonly used materials in pharmaceutical production both as inorganic carriers or active agents. The purpose of this study is the preparation and characterization of clay/antibacterial drug hybrids which can be further included in drug delivery systems for treatment oral infections. Novel nanocomposites with antibacterial properties were successfully prepared by ion exchange reaction from two types of kaolinite/urea intercalates and chlorhexidine diacetate. Intercalation compounds of kaolinite were prepared by reaction with solid urea in the absence of solvents (dry method) as well as with urea aqueous solution (wet method). The antibacterial activity of two prepared samples against Enterococcus faecalis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa was evaluated by finding the minimum inhibitory concentration (MIC). Antibacterial studies of both samples showed the lowest MIC values (0.01%, w/v) after 1 day against E. faecalis, E. coli and S. aureus. A slightly worse antibacterial activity was observed against P. aeruginosa (MIC 0.12%, w/v) after 1 day. Since samples showed very good antibacterial activity, especially after 1 day of action, this means that these samples can be used as long-acting antibacterial materials. Prepared samples were characterized by X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR). The experimental data are supported by results of molecular modelling." . "Saml\u00EDkov\u00E1, Magda" . "P(ED1.1.00/02.0070)" . "RIV/61989100:27640/14:86092158!RIV15-MSM-27640___" . . "7"^^ . . "Antibacterial kaolinite/urea/chlorhexidine nanocomposites: Experiment and molecular modelling"@en . . . "9"^^ . . "Antibacterial kaolinite/urea/chlorhexidine nanocomposites: Experiment and molecular modelling" . "Hole\u0161ov\u00E1, Sylva" .